EU recommends framework for patient safety with focus on healthcare-associated infections
This article was originally published in SRA
The European Commission has adopted a communication and a proposal for a council recommendation to improve patient safety in the European Union that encourages member states to collectively address areas of concern, including healthcare-associated infections, medical equipment-related failures and medication errors1-4. The decision has been prompted by data showing that around 8% to 12% of patients admitted to hospital experience adverse events while receiving healthcare.
You may also be interested in...
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.